Durability of treatment response following withdrawal from etanercept in psoriasis patients

被引：0
|
作者：
Gottlieb, A
Gordon, K
Wang, A
Zitnik, R
机构：
[1] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, New Brunswick, NJ USA
[2] Loyola Univ, Med Ctr, Maywood, IL 60153 USA
[3] Amgen Inc, Thousand Oaks, CA 91320 USA
来源：
JOURNAL OF INVESTIGATIVE DERMATOLOGY | 2004年 / 122卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
306
引用
收藏
页码：A51 / A51
页数：1
相关论文
共 50 条
  • [21] The role of inflammatory markers in assessing disease severity and response to treatment in patients with psoriasis treated with etanercept
    Kanelleas, A.
    Liapi, C.
    Katoulis, A.
    Stavropoulos, P.
    Avgerinou, G.
    Georgala, S.
    Economopoulos, T.
    Stavrianeas, N. G.
    Katsambas, A.
    CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2011, 36 (08) : 845 - 850
  • [22] Retreatment in patients with psoriasis achieving response with etanercept after relapse due to treatment interruption: results from the CRYSTEL study
    Griffiths, C. E. M.
    Luger, T. A.
    Brault, Y.
    Germain, J. M.
    Mallbris, L.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2015, 29 (03) : 468 - 473
  • [23] Real-World Experience with Etanercept Therapy and the Switching Pattern among Korean Patients with Psoriasis after Withdrawal of Etanercept
    Choi, Chong Won
    Lee, Ji Su
    Yu, Da-Ae
    Kim, Bo Ri
    Youn, Sang Woong
    ANNALS OF DERMATOLOGY, 2019, 31 (01) : 44 - 50
  • [24] Patient reported outcomes show improvement within 1 week in patients with psoriasis following etanercept treatment
    Serban, Anca
    Gottlieb, Alice
    Woolley, J. M.
    Lalla, D.
    Jahreis, A.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2007, 127 (07) : 1809 - 1809
  • [25] Cessation of cyclosporine therapy by treatment with etanercept in patients with severe psoriasis
    Yamauchi, PS
    Lowe, NJ
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2006, 54 (03) : S135 - S138
  • [26] Cessation of cyclosporine therapy by treatment with etanercept in patients with severe psoriasis
    Yamauchi, P
    Lowe, N
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2005, 52 (03) : P1 - P1
  • [27] Treatment of psoriasis with etanercept in immunocompromised patients: Two case reports
    De Simone, Clara
    Perino, Francesca
    Caldarola, Giacomo
    D'Agostino, Magda
    Peris, Ketty
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2016, 44 : 67 - 71
  • [28] Pharmacokinetics of etanercept in patients with psoriasis
    Nestorov, I
    DeVries, T
    Zitnik, R
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2004, 122 (03) : A55 - A55
  • [29] Etanercept as monotherapy in patients with psoriasis
    Leonardi, CL
    Powers, JL
    Matheson, RT
    Goffe, BS
    Zitnik, R
    Wang, A
    Gottlieb, AB
    Bagel, J
    Camisa, C
    Caro, I
    DiGiovanna, JJ
    Dunlap, FF
    Elewski, BE
    Gribetz, CE
    Farber, HF
    Feldman, SR
    Frankel, EH
    Gaspari, AA
    Goodman, JJ
    Gordon, KB
    Hampel, FC
    Herdener, RS
    Hoffman, MD
    Humeniuk, JM
    Johnson, SM
    Kang, S
    Kimball, AB
    Kirsner, RS
    Korman, NJ
    Krueger, GG
    Kuwahara, RT
    Lebwohl, M
    Ling, MR
    Liu, DC
    Lowe, N
    McCall, CO
    Menter, A
    Miller, BH
    Moore, JK
    Nayak, AS
    Ratner, PH
    Savin, RC
    Shupack, JL
    Smith, SL
    Stone, SP
    Swinehart, JM
    Taborn, J
    Tschen, EH
    Weinstein, GD
    Werth, VP
    NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (21): : 2014 - 2022
  • [30] Systemic profile of psoriasis: The effects of ustekinumab and etanercept following 12 weeks of treatment
    Brodmerkel, C.
    Li, K.
    Kikuchi, T.
    Fidelus-Gort, R.
    Khatcherian, A.
    Novitskaya, I.
    Baribaud, F.
    Krueger, J.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2009, 129 : S17 - S17
12345